EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS018-10119 
Organism
Homo sapiens 
Tissue/cell
CD19+ 
Coordinate
chr17:76918580-76921040 
TF binding sites/motifs
Number: 8             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr17:76920039-76920057AGAAGGAAGGAGGGCAGG+6.75
RREB1MA0073.1chr17:76919467-76919487TGGGGCGGGGTGGGGGGGGG-6.5
ZNF263MA0528.1chr17:76920848-76920869AAGGGAGAGGAGGGAGGGGGG+6.12
ZNF263MA0528.1chr17:76920040-76920061GAAGGAAGGAGGGCAGGGGGC+6.17
ZNF263MA0528.1chr17:76920850-76920871GGGAGAGGAGGGAGGGGGGAA+6.37
ZNF263MA0528.1chr17:76920853-76920874AGAGGAGGGAGGGGGGAAAGA+7.86
ZNF740MA0753.2chr17:76919479-76919492GGGGGGGGGGCGG-6.64
ZNF740MA0753.2chr17:76919476-76919489GTGGGGGGGGGGG-6.92
Number of super-enhancer constituents: 23             
IDCoordinateTissue/cell
SE_00300chr17:76910941-76921204Adipose_Nuclei
SE_01281chr17:76918769-76919388Adrenal_Gland
SE_01281chr17:76919592-76922635Adrenal_Gland
SE_02162chr17:76918754-76921396Aorta
SE_03993chr17:76915925-76921162Brain_Anterior_Caudate
SE_04879chr17:76915816-76921191Brain_Cingulate_Gyrus
SE_05810chr17:76911306-76922885Brain_Hippocampus_Middle
SE_06786chr17:76916161-76918999Brain_Hippocampus_Middle_150
SE_06786chr17:76919170-76922733Brain_Hippocampus_Middle_150
SE_07878chr17:76915717-76919471Brain_Inferior_Temporal_Lobe
SE_07878chr17:76919474-76920837Brain_Inferior_Temporal_Lobe
SE_09297chr17:76910944-76922621CD14
SE_37084chr17:76919118-76921123HSMMtube
SE_42323chr17:76918794-76922738Lung
SE_44678chr17:76918740-76921185NHDF-Ad
SE_44776chr17:76919718-76920951NHLF
SE_46643chr17:76920031-76920661Ovary
SE_46643chr17:76920702-76921196Ovary
SE_47655chr17:76919024-76921468Pancreas
SE_48820chr17:76918832-76919465Right_Atrium
SE_48820chr17:76919493-76921151Right_Atrium
SE_53624chr17:76917235-76922732Spleen
SE_65313chr17:76918500-76921008Pancreatic_islets
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr177691900076919402
chr177691984476920193
Enhancer Sequence
TCCAATGGCT GCTGTCCTTA GAAGAACAGG GCAATTTGGC CGGGCGCGGT GGCTCACGCC 60
TATAATCCCA GCACTTTGGG AGGCTGAGGC AGGCGGATCA CCTGAGGCCA GGAGTTCGAG 120
ACCAGCCTGG CCAACATGGC GAATTCCTGT CTCTACTAAA AATACAAAAA ATTAGCCGGG 180
TGTGGTGGCA GGTGCCTGTA ACCCCAGCTA CTTGGGAGGC TGAGGCAGGA GAATTGCTCG 240
AACCCAGGAG GCGGAGGCTG CAGCGAGCCG AGATTGCGCC ATTGCACTCC AGCCTGCTCT 300
CCAAAAAAAA AGAACAGGGA AATTTGGACA CAGAGACACA CGAGAGAAGG CCATGTGAAG 360
ACAGGCGGAA ATGGAAGTGA TGTGTTCCTT GAAAATGGAA CCAAGCAACA TCAAGGAGAG 420
AGGCCTGGAA GAGATTCTCC CTCACAGCCC CCAGAAGGAA CTGGCTCTGT GGACACCTTT 480
TCAGACTTCT GGCCTCCTGA GCTACAGAGA ATCGATTCCT GTTCTTTTAA GCCCTCCCAT 540
TTGTGGTAGT TTGTCACAGC GGCCACAGGA AGCGAATGCC CTGAGCTCTG CAGTGCAACT 600
CTGGCATCTG ACTGGGCCTC TGAGCCGGGA TGGGGTGAAA AGTTTTAGCT ACAGGATGAT 660
TTTGATGCAA AGATTTAGAC ACAAATGCCA GGCAACCCAG AAGAGGAGAG TGCTGCGCTG 720
AGCATGAAGG AGGCGGGAGG CACGCACTGC AGCCCTCCAC CCTCTGCCAT CCTGGATCCA 780
CACCCCACGC AGAAACAGCT CCCAGCTCAG TGGCCGCCTT AACTTATGCC AAGCAAGGAC 840
AGAGTGGCTG CCTGGACATT CTCCCACACA GCTGAGGAGT GTGTGTGTGG GGCGGGGTGG 900
GGGGGGGGGC GGGAGGGGGA GGGGTCCCAA GGCCCAACTC CTACAAATCC AACTCCCAGG 960
TCCTTTTATC CACAGCCTCC TTCTGGGCCT TGGCTACATC CTGCCCCAGC ACGTGCTGGT 1020
GAGCCAAGGA GCCTGGACAG GCCTGCACTC CTCGTGGACC CCCAGAGAAA GGCCCATTAT 1080
GGCTCCCTCA TCAAAGGAAC CTCTCCTTCA CCCACAAATC TTGCTGAGCA CCAAGGCTAA 1140
ACTGGAGAAA AGACCTCATT TCCCCCAAAC TGGGTTTTGT GGAAACTGAC ACAGGCACAC 1200
ACCAAGCCTT CCGCCCAGGT GGCCTGAGCC ACCTGAGACC TGTGATCTCA ATAGATTGGT 1260
GCAACTGAAA ACTTCCCCAG CTGGGCACGC AGCTCCTAGG GCTAACCGGG GTGGGGCAAG 1320
AAGCCGTGGG CGGGGTATGG GAAGGGCGTG GCTGACAGCA GGAGAAACAG AAAGTCCCAC 1380
CTCCACTCTG GGCAGGTGAG GGGGCCCCCG CCTTGCTCCA TCTGCCCTGG ACAGGTCACT 1440
CGACTGAGAC TCAGACATAA GAAGGAAGGA GGGCAGGGGG CTCCGAGACC ACCTGCCGTG 1500
TAGCCAGACT TGCCCCAGGA AAACCATGCT GACCAGCACC AGGGCTGCAG AGGCTTGAGG 1560
TGCAGGACCA GGGTGGAAAC TTCGAGCCAG CGGGTTCCTC CCATTTCTGC TGGTCCTCCC 1620
CCTCCATGGA TCAGAACAAA TAACTGGGCC CCTCCTGCCT CCCTCCATGG CGCCTGTCTT 1680
TTGGGGGCTA GGAGTCCGGA GGTCATGGGT ATTTGCTGGG GAATCTGAGC AGCAGCACAG 1740
TCCCACGTGC CGGGTCCGGT CACCAAAGTC TCCAGCTTTT GTGGACGTCC CGAAAAAGCG 1800
GAACATTCGG GGGTCCCGGT CCCTGCCCAG CCAGTTTGCA GGGCCTCCTG GGCAGGGCGC 1860
AAGCAAGGAG CCACGCCAGG AGACGCCACC GGCTTTTTCA CCTGCCCCTC TGGGCCTGTG 1920
GAACCTGCCT CGGGTAGGGC GGGCTTCCAT CCCACCCTGG CTTGATCGGG GAGCCCCCAA 1980
ATGGGGCTGG TGGGAGAAGC CCCAGCAGAG AAGCCCTTCC CCACCCAGCC CCAAGCCCAG 2040
AGAAGCCCAA CTCCCACCTT ATCTGCGAAA GTTTCTTCCT GGGGTCCCCA GTCCTCCAGC 2100
CCCCCGCCCC CACGCCGTGT CCCCCACGCT CCCCGCCCCC AGCGCTGGCA TCCCAGGGCG 2160
CGCCGCCTGC CAAAAGCCAA ACTGGCTCCC TTTCCTGGGG CTGGAGCTGC GGCGGAATTT 2220
CGGTGGAATT TTGAGGTTGA GACGCATCTC GGCAAAGAGA GGGAAAGAAA GGGAGAGGAG 2280
GGAGGGGGGA AAGAAAGTCG GCTCTGGGCG TCCACTTGCA GGATTCGAGA AGGCGCCGAG 2340
GGACCAGGAG GCGGGCGCTG GGGTCCCTCG GCCAGCGGCG GGCGGGCGGG GCGTCTGCGA 2400
ACCCTCGGGG TCGCGGGGGA GGTGGGGCCC CGCGCGGGGG CTGGGGTCGC CGCTCCTTAC 2460